These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 22105468

  • 1. Potential role of prolactin in antipsychotic-mediated association of schizophrenia and type 2 diabetes.
    Oberweis B, Gragnoli C.
    J Cell Physiol; 2012 Aug; 227(8):3001-6. PubMed ID: 22105468
    [Abstract] [Full Text] [Related]

  • 2. Atypical antipsychotics: mechanism of action.
    Seeman P.
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [Abstract] [Full Text] [Related]

  • 3. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
    Silvestre JS, Prous J.
    Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G, Butini S, Fattorusso C, Catalanotti B, Gemma S, Nacci V, Morelli E, Cagnotto A, Mereghetti I, Mennini T, Carli M, Minetti P, Di Cesare MA, Mastroianni D, Scafetta N, Galletti B, Stasi MA, Castorina M, Pacifici L, Vertechy M, Di Serio S, Ghirardi O, Tinti O, Carminati P.
    J Med Chem; 2004 Jan 01; 47(1):143-57. PubMed ID: 14695828
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dopamine and serotonin receptor binding and antipsychotic efficacy.
    Richtand NM, Welge JA, Logue AD, Keck PE, Strakowski SM, McNamara RK.
    Neuropsychopharmacology; 2007 Aug 01; 32(8):1715-26. PubMed ID: 17251913
    [Abstract] [Full Text] [Related]

  • 8. Potential role of 5-HT2 and D2 receptor interaction in the atypical antipsychotic action of the novel succimide derivative, perospirone.
    Ohno Y, Ishida-Tokuda K, Ishibashi T, Sakamoto H, Tagashira R, Horisawa T, Yabuuti K, Matsumoto K, Kawabe A, Nakamura M.
    Pol J Pharmacol; 1997 Aug 01; 49(4):213-9. PubMed ID: 9437764
    [Abstract] [Full Text] [Related]

  • 9. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
    Newcomer JW.
    J Clin Psychiatry; 2004 Aug 01; 65 Suppl 18():36-46. PubMed ID: 15600383
    [Abstract] [Full Text] [Related]

  • 10. Receptor mechanisms in the treatment of schizophrenia.
    Reynolds GP.
    J Psychopharmacol; 2004 Sep 01; 18(3):340-5. PubMed ID: 15358977
    [Abstract] [Full Text] [Related]

  • 11. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
    Haleem DJ.
    J Coll Physicians Surg Pak; 2006 Aug 01; 16(8):556-62. PubMed ID: 16899192
    [Abstract] [Full Text] [Related]

  • 12. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE.
    J Clin Psychiatry; 2004 Aug 01; 65 Suppl 9():25-8. PubMed ID: 15189109
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neurobiological background for the development of new drugs in schizophrenia.
    López-Muñoz F, Álamo C.
    Clin Neuropharmacol; 2011 Aug 01; 34(3):111-26. PubMed ID: 21586917
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of serotonin receptors in the action of atypical antipsychotic drugs.
    Meltzer HY, Massey BW.
    Curr Opin Pharmacol; 2011 Feb 01; 11(1):59-67. PubMed ID: 21420906
    [Abstract] [Full Text] [Related]

  • 20. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V, Doknic M, Maric N, Pekic S, Damjanovic A, Miljic D, Popovic S, Miljic N, Djurovic M, Jasovic-Gasic M, Dieguez C, Casanueva FF.
    Neuroendocrinology; 2007 Feb 01; 85(4):249-56. PubMed ID: 17570902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.